Daily Anesthesiology Research Analysis
Three high-impact anesthesiology studies stand out: a dual-centre randomized trial shows that intubation in the thyroid surgical position significantly improves intraoperative neuromonitoring reliability in thyroidectomy; a double-blind pediatric RCT demonstrates brachial plexus block markedly reduces pain and improves procedural efficiency during PICC placement; and a large randomized trial indicates ciprofol plus remimazolam yields safer hemodynamics than propofol for gastroscopy sedation.
Summary
Three high-impact anesthesiology studies stand out: a dual-centre randomized trial shows that intubation in the thyroid surgical position significantly improves intraoperative neuromonitoring reliability in thyroidectomy; a double-blind pediatric RCT demonstrates brachial plexus block markedly reduces pain and improves procedural efficiency during PICC placement; and a large randomized trial indicates ciprofol plus remimazolam yields safer hemodynamics than propofol for gastroscopy sedation.
Research Themes
- Airway and neuromonitoring optimization in thyroid surgery
- Pediatric regional anesthesia for procedural pain control
- Sedation pharmacology: hemodynamic safety of novel agent combinations
Selected Articles
1. Tracheal intubation in the thyroid surgical position improves recurrent laryngeal nerve monitoring: a dual-centre randomised trial.
Intubating patients in the thyroid surgical position increased the proportion of satisfactory vagus nerve EMG signals (>500 μV) compared with standard supine intubation, without added complications or intubation difficulty. Clinician satisfaction and mask ventilation ratings were higher, suggesting a simple, scalable change to improve IONM reliability.
Impact: This pragmatic RCT provides actionable evidence that a minor positioning change enhances neuromonitoring fidelity in thyroidectomy, potentially reducing recurrent laryngeal nerve injury risk.
Clinical Implications: Adopt thyroid surgical positioning before EMG-tube intubation in thyroidectomy to improve IONM signal adequacy, with no trade-off in safety or intubation difficulty.
Key Findings
- Satisfactory V1 EMG signals were higher in the thyroid-position group: 96.47% vs 85.37% (RR 1.13; 95% CI 1.03–1.24; P=0.0145).
- No significant differences in intubation time or Cormack–Lehane grade between groups.
- Slightly deeper EMG tube insertion was required in the thyroid-position group; postoperative complications were similar.
- Clinician and mask ventilation satisfaction were significantly higher in the thyroid-position group.
Methodological Strengths
- Dual-centre, randomised, parallel-group design with modified intention-to-treat analysis.
- Predefined, objective EMG amplitude threshold for satisfactory signal; comprehensive perioperative outcomes.
Limitations
- Blinding was not feasible, potentially introducing performance bias.
- Generalizability may be limited to centres using standardized EMG tubes and IONM protocols.
Future Directions: Evaluate impacts on RLN injury rates and voice outcomes, and assess applicability across diverse devices and surgical teams in multicentre pragmatic trials.
BACKGROUND: Intraoperative neuromonitoring (IONM) is a critical adjunct in thyroid surgery to preserve recurrent laryngeal nerve (RLN) function. This study aims to evaluate whether tracheal intubation in the thyroid surgical position enhances IONM signal quality compared to the standard supine position. METHODS: In this dual-centre, parallel-group, randomised trial, 184 adults scheduled for elective thyroidectomy requiring IONM were allocated 1:1 to intubation in either the thyroid surgical position or the conventional supine position. The modified intention-to-treat cohort comprised 167 participants (85 vs 82) with an assessable baseline vagus response (V1). The primary outcome was the incidence of satisfactory electromyography (EMG) signals, defined as an initial vagus nerve EMG amplitude exceeding 500 μV when stimulated at 1.0 mA. Secondary outcomes included EMG signal amplitude, intubation-related metrics (e.g., Cormack-Lehane grades, intubation difficulty scale scores, intubation time, and depth of intubation), postoperative complications (e.g., lip lesions, dental injury, postoperative nausea and vomiting, dizziness, and headache), and clinician satisfaction with patient positioning and mask ventilation. RESULTS: Satisfactory V1 signals occurred in 82/85 patients (96.47 %) in the thyroid-surgical-position group versus 70/82 (85.37 %) in the supine group (relative risk 1.13; 95 % CI 1.03-1.24; P = 0.0145). Intubation time and Cormack-Lehane grades did not differ significantly, but the Thyroid Surgical Position Group required deeper EMG tube insertion (22 cm [21-23] vs. 22 cm [21-22]; median differences 1.1, 95% CI 0-1; P = 0.046). Postoperative complications did not differ significantly between groups (all P > 0.05). Clinician satisfaction scores were significantly higher in the Thyroid Surgical Position Group (median 9 vs. 5; median differences 4, 95% CI 3-4; P < 0.0001). Mask ventilation satisfaction was also rated higher in the Thyroid Surgical Position Group (median 9 vs. 8; median differences 1, 95% CI 0-1 P < 0.0001). CONCLUSIONS: Tracheal intubation in the thyroid surgical position significantly improves IONM signal quality and clinician satisfaction without increasing intubation difficulty or postoperative complications. Adopting this simple positioning strategy can optimise EMG tube placement and enhance the reliability of IONM during thyroid surgery.
2. Brachial Plexus Block Reduces Pain Scores During Peripherally Inserted Central Catheter Placement in Neonates and Pediatric Patients Compared to Local Infiltration Anesthesia: A Randomized, Double-Blind, Single-Center Study.
In a double-blind pediatric RCT, brachial plexus block dramatically reduced procedural pain during PICC placement versus local infiltration, with better first-pass success, fewer punctures, and shorter procedure time. Ultrasound guidance supported high efficacy and safety.
Impact: Provides high-quality evidence for adopting regional anesthesia to improve pain control and procedural outcomes for a common pediatric procedure.
Clinical Implications: Consider brachial plexus block (ultrasound-guided) as standard analgesia for pediatric PICC placement to reduce distress and enhance efficiency, with appropriate expertise and monitoring.
Key Findings
- Comfort Neo pain scores markedly lower with brachial plexus block at puncture (median 6 vs 30) and at 30 minutes (6 vs 22), both p<0.0001.
- Higher first-attempt success (61% vs 38%) and fewer puncture attempts (median 1 vs 2).
- Shorter procedure time (median 30 vs 40 minutes) and reduced rescue analgesic use and pain-related movement.
Methodological Strengths
- Randomized, double-blind design with clear primary and secondary outcomes.
- Ultrasound-guided techniques standardize block placement and enhance reproducibility.
Limitations
- Single-center study with modest sample size may limit generalizability.
- Short-term outcomes; long-term safety and feasibility across diverse settings not assessed.
Future Directions: Multicentre trials to confirm efficacy, assess block-related complications, and evaluate implementation frameworks in neonatal and pediatric settings.
BACKGROUND: Effective pain management during peripherally inserted central catheter placement in neonates and pediatric patients remains challenging, often leading to procedural distress and suboptimal outcomes. AIM: This randomized controlled trial aimed to evaluate the analgesic efficacy of brachial plexus block compared to local infiltration anesthesia during peripherally inserted central catheter placement. METHODS: Seventy patients were randomized into two groups: brachial plexus block (Group B) and local infiltration anesthesia (Group C). Procedural pain was assessed using the Comfort Neo Scale at T = 0 min (puncture) and T = 30 min (30 min after the procedure). Secondary outcomes included the first-attempt success rate, procedure time, number of puncture attempts, and rescue analgesic use. All interventions were performed under ultrasonographic guidance. Continuous data are expressed as medians [interquartile range (IQR)]. RESULTS: The median Comfort Neo Scale scores at T = 0 were significantly lower in Group B (6 [6-6]) than in Group C (30 [30-30]; difference: -24, 95% CI: -24 to -24, p < 0.0001). At T = 30, the scores remained lower in Group B (6 [6-6]) than in Group C (22 [12-30]; difference: -16, 95% CI: -19 to -10, p < 0.0001). Group B also demonstrated shorter procedure times (30 [20-30] vs. 40 [30-50] min; difference: -10 min, 95% CI: -20 to -10, p < 0.0001), higher first-attempt success rates (61% vs. 38%; odds ratio: 0.08, 95% CI: 0.03-0.26, p < 0.0001), and fewer puncture attempts (1 [1-2] vs. 2 [1-3]; difference: -1, 95% CI: -2 to 0, p < 0.001). Rescue analgesic use and pain-related movements were significantly reduced in Group B (odds ratio for pain-related movement: ∞, 95% CI: 109-∞, p < 0.0001). CONCLUSIONS: Brachial plexus block provides superior pain relief and procedural outcomes compared to local infiltration anesthesia during peripherally inserted central catheter placement in neonates and pediatric patients. Its adoption as a standard pain management approach can enhance patient comfort, improve efficiency, and reduce procedural distress. Future studies should explore the broad applicability and long-term benefits of this approach. TRIAL REGISTRATION: Japan Registry of Clinical Trials (jRCT): jRCT1010220045.
3. Intravenous Anesthesia with Ciprofol and Remimazolam Besylate for Painless Gastroscopy: A Prospective, Single-Center, Randomized Controlled Trial.
Among 641 randomized patients, ciprofol plus remimazolam reduced hypotension compared with propofol, and ciprofol alone also showed benefit. BIS-guided sedation was achieved with fewer hemodynamic perturbations, suggesting a safer profile for endoscopic sedation.
Impact: Novel combination of two newer agents demonstrates improved hemodynamic safety over propofol for a ubiquitous procedure, supporting broader adoption of safer sedation regimens.
Clinical Implications: For routine gastroscopy, consider ciprofol plus remimazolam to mitigate hypotension while maintaining adequate sedation, particularly in patients at risk of hemodynamic instability.
Key Findings
- Ciprofol + remimazolam lowered hypotension incidence versus propofol (7.8% vs 21.6%); ciprofol alone also reduced hypotension (12.3% vs 21.6%).
- Target BIS 40–60 achieved with supplemental dosing while maintaining better hemodynamic stability.
- Safety and efficacy favored the combination over either monotherapy for painless gastroscopy.
Methodological Strengths
- Large randomized controlled trial (n=641) with BIS-guided sedation across three arms.
- Direct head-to-head comparison with propofol, the current standard, enhances clinical interpretability.
Limitations
- Single-center study; blinding status not clearly reported in the abstract.
- Abstract truncation limits visibility of full safety and respiratory outcomes.
Future Directions: Multicentre, blinded trials with comprehensive respiratory endpoints and high-risk subgroups to confirm safety and generalizability.
PURPOSE: To evaluate whether combining ciprofol and remimazolam offers superior safety and efficacy compared to propofol or ciprofol monotherapy for sedation during painless gastroscopy. We hypothesize improved hemodynamic and respiratory stability with the combination. METHODS: A total of 641 patients undergoing gastroscopy were randomly assigned to one of three groups. Group P (Propofol) received an intravenous bolus of propofol at a dose of 1.5 mg/kg. Group CR (Ciprofol + Remimazolam) received an initial intravenous dose of remimazolam (0.08 mg/kg), followed by ciprofol (0.25 mg/kg). Group C (Ciprofol) received an intravenous bolus of ciprofol at a dose of 0.4 mg/kg. Sedation depth was maintained within the target range (Bispectral Index 40-60) through the administration of supplemental doses: propofol (10-20 mg boluses) in Group P, and ciprofol (2.5-5 mg boluses) in Groups CR and C. RESULTS: Compared with group P, groups CR and C demonstrated significantly lower incidences of hypotension (CR: 7.8% vs P: 21.6%; C: 12.3% vs P: 21.6%; all CONCLUSION: The combination of ciprofol and remimazolam exerts a lesser impact on the respiration and circulation of patients undergoing gastroscopy, and demonstrates superior safety and efficacy compared to the use of propofol or ciprofol alone.